Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.3863 USD | -0.95% | -8.35% | -41.84% |
Financials (USD)
Sales 2023 * | 700K | Sales 2024 * | 700K | Capitalization | 10.01M |
---|---|---|---|---|---|
Net income 2023 * | -13M | Net income 2024 * | -15M | EV / Sales 2023 * | 14.3 x |
Net cash position 2023 * | - | Net cash position 2024 * | - | EV / Sales 2024 * | 14.3 x |
P/E ratio 2023 * |
-0.84
x | P/E ratio 2024 * |
-0.92
x | Employees | 33 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 58.27% |
Latest transcript on BioCardia, Inc.
1 day | -0.95% | ||
1 week | -8.35% | ||
Current month | -29.76% | ||
1 month | -13.96% | ||
3 months | -40.66% | ||
6 months | +3.29% | ||
Current year | -41.84% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Altman
CEO | Chief Executive Officer | 57 | 01-12-31 |
David McClung
DFI | Director of Finance/CFO | 61 | 13-08-31 |
Chief Tech/Sci/R&D Officer | - | 17-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Simon Stertzer
BRD | Director/Board Member | 88 | 01-12-31 |
Jay Moyes
BRD | Director/Board Member | 70 | 10-12-31 |
Richard Krasno
BRD | Director/Board Member | 82 | 16-10-23 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 0.3863 | -0.95% | 118,686 |
24-03-15 | 0.39 | -0.86% | 155,697 |
24-03-14 | 0.3934 | +1.03% | 295,080 |
24-03-13 | 0.3894 | +2.07% | 810,107 |
24-03-12 | 0.3815 | -9.49% | 4,614,325 |
Delayed Quote Nasdaq, March 18, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-41.84% | 10.11M | |
+1.10% | 105B | |
+9.29% | 104B | |
-3.00% | 22.09B | |
-11.89% | 21.98B | |
-26.59% | 20.17B | |
-5.20% | 19.49B | |
-6.58% | 17.75B | |
+5.83% | 13.84B | |
+7.46% | 11.64B |